Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of LY2584702 in Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: November 12, 2010
Last updated: November 17, 2011
Last verified: November 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)